Updated guidelines standardize how tumor response is measured after surgery

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have released updated consensus guidelines and an associated reproducibility study to standardize how pathologists assess tumor response to neoadjuvant therapy (administered prior to surgery) across a dozen solid tumor types.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup